These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1968207)

  • 21. Intravenous recombinant tissue-type plasminogen activator in acute myocardial infarction.
    Gao R; Chen J; Kou W; Yao K; Xu Y; Lu Z; Yu Q; Tao P; Ma J; Zhu J
    Chin Med Sci J; 1991 Sep; 6(3):132-5. PubMed ID: 1793874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes in the plasma levels of fibrinopeptide A in acute myocardial infarction after administration of intravenous streptokinase].
    Amoriello A; Piantadosi FR; Piccenna L; Amoriello A; Vacca C; Eliseo V
    Cardiologia; 1988 Dec; 33(12):1121-6. PubMed ID: 3255497
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of thrombolytic therapy on hemoglobin change after acute myocardial infarction.
    Tahnk-Johnson ME; Sharkey SW
    Am J Cardiol; 1993 Apr; 71(10):869-72. PubMed ID: 8456772
    [No Abstract]   [Full Text] [Related]  

  • 24. Thrombolytic therapy of myocardial infarction--it's time for science, not marketing: the perspective of a practicing cardiologist.
    Vogel JH
    Clin Cardiol; 1991 Jul; 14(7):548. PubMed ID: 1810292
    [No Abstract]   [Full Text] [Related]  

  • 25. Angiographic studies demonstrating the need for conjunctive anticoagulation.
    Bleich SD
    Coron Artery Dis; 1996 Jul; 7(7):516-21. PubMed ID: 8913669
    [No Abstract]   [Full Text] [Related]  

  • 26. Perspectives on therapeutic interventions in patients with acute myocardial infarction: viewpoints after the GISSI-2 results.
    Maggioni AP; Franzosi MG; Malacrida R; Tognoni G
    Clin Cardiol; 1991 Jul; 14(7):549-56. PubMed ID: 1747963
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trials and decisions for thrombolytic therapy in patients with acute myocardial infarction.
    Conti CR
    Clin Cardiol; 1990 May; 13(5):307-8. PubMed ID: 2112073
    [No Abstract]   [Full Text] [Related]  

  • 29. TNK-tPA: a new thrombolytic for treatment of acute myocardial infarction.
    Johnson TJ
    S D J Med; 2000 May; 53(5):185-6. PubMed ID: 10835948
    [No Abstract]   [Full Text] [Related]  

  • 30. Thrombin inhibition and coronary artery thrombolysis.
    Yao SK; McNatt JM; Anderson HV; Eidt JF; Cui KX; Golino P; Glas-Greenwalt P; Maraganore JM; Buja LM; Willerson JT
    Trans Assoc Am Physicians; 1990; 103():1-9. PubMed ID: 2132522
    [No Abstract]   [Full Text] [Related]  

  • 31. Thrombolytic therapy for acute myocardial infarction: GUSTO criticized.
    Chelluri L; Sirio CA; Angus DC
    N Engl J Med; 1994 Feb; 330(7):505; author reply 505-6. PubMed ID: 8289862
    [No Abstract]   [Full Text] [Related]  

  • 32. What you should know about thrombolytic therapy for acute MI.
    Aragon D; Martin M
    Am J Nurs; 1993 Sep; 93(9):24-31; quiz 33. PubMed ID: 8213959
    [No Abstract]   [Full Text] [Related]  

  • 33. [The identification of the best thrombolytic. Reflections on a problem without resolution].
    Betriu A
    Rev Esp Cardiol; 1993 Apr; 46(4):242-5. PubMed ID: 8469809
    [No Abstract]   [Full Text] [Related]  

  • 34. Thrombolytic therapy for vascular occlusions.
    Gibbons KJ; Guterman LR; Ahuja A; Hopkins LN
    J Neurosurg; 1992 Jan; 76(1):168-9. PubMed ID: 1727158
    [No Abstract]   [Full Text] [Related]  

  • 35. [Plasmin-mediated activation of the coagulation system. A study of patients with acute ischemic heart disease treated with recombinant tissue-plasminogen activator].
    Gram JB; Munkvad S; Leebeek FW; Kluft C; Jespersen J
    Ugeskr Laeger; 1994 May; 156(18):2746-8, 2751-2. PubMed ID: 8009715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators
    N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracerebral hematoma related to thrombolysis for myocardial infarction.
    Kaufman HH; McAllister P; Taylor H; Schmidt S
    Neurosurgery; 1993 Nov; 33(5):898-900; discussion 900-1. PubMed ID: 8264890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GUSTO (Global Utilization of Streptokinase and Tissue plasminogen activator in Occluded arteries): logic wins at last.
    Bassand JP
    Eur Heart J; 1994 Jan; 15(1):2-4. PubMed ID: 8174579
    [No Abstract]   [Full Text] [Related]  

  • 39. [Coronary thrombolysis in patients with acute myocardial infarction].
    Kambara H; Fudo T; Ono S
    Kokyu To Junkan; 1992 Jun; 40(6):537-47. PubMed ID: 1620990
    [No Abstract]   [Full Text] [Related]  

  • 40. Thrombolytic therapy in acute myocardial infarction following prolonged cardiopulmonary resuscitation.
    Neches RB; Goldfarb AM; Saviano GJ
    Clin Cardiol; 1991 Jul; 14(7):616-9. PubMed ID: 1747973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.